We are experiencing extremely high call volume related to COVID-19 vaccine interest. Please understand that our phone lines must be clear for urgent medical care needs. We are unable to accept phone calls to schedule COVID-19 vaccinations at this time. When this changes, we will update this web site. Please know that our vaccine supply is extremely small. Read all COVID-19 Vaccine Information.
Patient Care Options | Visitor Guidelines | Coronavirus Information | Self-Checker | Get Email Alerts
Enter the last name, specialty or keyword for your search below.
IRB # 04-06-18-06
Principal Investigator: Michael Polydefkis 410.502.7610
The goal of this collaboration between the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center and the Neurology department is to characterize the pattern of nerve injury in people receiving oxaliplatin as part of a chemotherapy regimen to treat colon cancer. As a result of this study, we hope to identify the best technique to detect prevention of oxaliplatin-induced peripheral neuropathy as well as to identify people at risk for oxaliplatin-induced neuropathy.
1. Informed Consent
2. Diagnosis of colon cancer who are about to start taking oxaliplatin
3. 18-85 years old
1. Low platelet counts and/or the use of blood thinners other than aspirin
2. Previous neurotoxic exposure
IRB# 03-11-02-01
Principal Investigator: Michael Polydefkis 410.502.7610
This research is being conducted to better understand the relationship between mildly elevated blood sugar levels and neuropathy, and how the two interact with each other over the course of many years. The study involves peripheral nerve examination including nerve conduction testing and punch skin biopsy on a yearly basis.
1. Informed consent
2. Impaired glucose tolerance or a recent diagnose of diabetes in the setting of peripheral neuropathy
3. Age between 18 and 80 years
1. Diagnosed with any of the following conditions:
• Systemic disease other than diabetes that is associated with peripheral neuropathy
• A significant disorder or a condition other than diabetes that can cause symptoms or physical conditions that mimic peripheral neuropathy
2. People on blood thinning medications such as coumadin, but not aspirin
Request an Appointment
Maryland Patients
Thank you for your interest in the Johns Hopkins Peripheral Nerve Center.
Adult Neurology: 410-955-9441
Pediatric Neurology: 410-955-4259
Already a Patient?
Traveling for Care?
Whether you're crossing the country or the globe, we make it easy to access world-class care at Johns Hopkins.
Outside of Maryland (toll free)
410-464-6713
Request an Appointment
Medical Concierge Services
International Patients
+1-410-502-7683
Request an Appointment
Medical Concierge Services
Language Assistance Available:
© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.
